In normotensive humans, endothelium modulates vascular tone mainly by
the production of nitric oxide. In human essential hypertension the ba
sal release of nitric oxide is reduced and forearm vasodilation to the
endothelium-dependent agonists acetylcholine or bradykinin is blunted
. Defective basal release of nitric oxide seems to be secondary to blo
od pressure increase while impaired agonist-evoked endothelium-depende
nt vasodilation is probably a primary phenomenum. This latter endothel
ial dysfunction seems to be caused by the simultaneous presence of an
alteration in the L-arginine-nitric oxide pathway and the production o
f constrictor prostanoids. Defective nitric oxide production is alread
y detectable in normotensive offspring of hypertensive patients and yo
ung essential hypertensives. In contrast, vasoconstrictor prostanoid p
roduction seems to be associated with aging. In essential hypertensive
patients, although only scanty data are available, chronic effective
pharmacological treatment seems to restore impaired basal production o
f nitric oxide but does not improve vascular response to endothelial a
gonists.